Allergan Inc (NYSE:AGN)

161.82
Data as of Aug 19
 +6.21 / +3.99%
Today’s Change
86.95
Today|||52-Week Range
174.49
+45.68%
Year-to-Date
Aug. 20 Premarket Briefing: 10 Things You Should Know
6:39am / TheStreet.com
Notable Hedge Funds Disclose Additions And Reductions To Holdings
Aug 15 / Benzinga
Benzinga's M&A Chatter for Tuesday August 19, 2014
Aug 19 / Benzinga
A Winning Biotech Strategy
Aug 14 / Investing Channel
Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog
Aug 19 / Zacks.com
Bill Ackman plans to raise $4bn by listing new investment vehicle
Aug 13 / FT.com
Novo Nordisk to Pay Fine, Tresiba in Focus - Analyst Blog
Aug 19 / Zacks.com
Synergy Pharma (SGYP) Posts Wider-than-Expected Loss in Q2 - Analyst Blog
Aug 13 / Zacks.com
Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs
Aug 19 / Benzinga
Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog
Aug 13 / Zacks.com
Market Wrap: Housing Starts Rip Higher in July; Allergan Fends-Off Takeover; Apple at...
Aug 19 / Investing Channel
Bill Ackman On Why Using Debt To Buyback Stock Is Great And Much More: Full Q2 Invest...
Aug 13 / Investing Channel
Allergan On The Acquisition Hunt
Aug 19 / Benzinga
ICU Medical, Inc. (ICUI) Jumps: Stock Adds 9.8% in Session - Tale of the Tape
Aug 13 / Zacks.com
Why Salix Pharmaceuticals (SLXP) Stock Is Soaring Today
Aug 19 / TheStreet.com
Frontrunning: August 13
Aug 13 / Investing Channel
Salix Pharmaceuticals Ltd. (SLXP) Approached by Allergan Inc. (AGN)
Aug 19 / Investing Channel
Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog
Aug 12 / Zacks.com
Eli Lilly-Boehringer's Insulin Drug Gets Tentative FDA Nod - Analyst Blog
Aug 19 / Zacks.com
Auxilium Posts Wider-than-Expected Loss, Outlook Maintained - Analyst Blog
Aug 12 / Zacks.com
AstraZeneca's Asthma Drug in Focus, Phase III Study Initiated - Analyst Blog
Aug 18 / Zacks.com
Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales - Analyst Blog
Aug 08 / Zacks.com
Roche's Avastin Approved by FDA for Advanced Cervical Cancer - Analyst Blog
Aug 18 / Zacks.com
OncoGenex Q2 Loss Narrower than Expected, Revenues Down Y/Y - Analyst Blog
Aug 08 / Zacks.com
Is The SEC Asking These Hedge Funds Why They All Rushed Into Allergan Last Quarter?
Aug 18 / Investing Channel
Can Allergan Inc. (AGN) Stock Continue to Grow Earnings? - Tale of the Tape
Aug 08 / Zacks.com
Why Valeant (VRX) Stock Is Lower Today
Aug 18 / TheStreet.com
Charles River Beats on Q2 Earnings & Revenues, Outlook Upped - Analyst Blog
Aug 07 / Zacks.com
AstraZeneca's Gout Drug in Focus with Phase III Data Readout - Analyst Blog
Aug 15 / Zacks.com
Allergan files insider trading lawsuit against suitors
Aug 01 / FT.com
Allergan Takes In 13 New Hedge Fund Investments In Q2
Aug 15 / Benzinga
Regional banks slip after BB&T setback
Jul 21 / FT.com
IRS to probe Valeant tax returns after Canada deal
Aug 15 / FT.com
Allergan to cut 1,500 jobs as it fights Valeant takeover bid
Jul 21 / FT.com
What The Best Hedge Funds Are Buying
Aug 15 / Investing Channel
Stocks: Obama's words soothe markets
Jul 21 / CNNMoney.com
3 Drugs Stocks Moving The Industry Upward
Aug 15 / TheStreet.com
Stocks: 5 things to know before the open
Jul 21 / CNNMoney.com
Frontrunning: August 15
Aug 15 / Investing Channel
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.